[HTML][HTML] The mother-to-child transmission of HIV-1 and profile of viral reservoirs in pediatric population: A systematic review with meta-analysis of the Cameroonian …

…, E Ngoufack Jagni Semengue, AJ Nanfack… - PLoS …, 2023 - journals.plos.org
Background The mother-to-child transmission of HIV-1 (MTCT) remains on the major route
of HIV-transmission among pediatric populations in Africa. Though a prevention of MTCT (…

[HTML][HTML] Dynamics and durability of HIV-1 neutralization are determined by viral replication

…, A Adhikari, S Esser, H Streeck, R Duerr, AJ Nanfack… - Nature Medicine, 2023 - nature.com
Human immunodeficiency virus type 1 (HIV-1)-neutralizing antibodies (nAbs) that prevent
infection are the main goal of HIV vaccine discovery. But as no nAb-eliciting vaccines are yet …

[HTML][HTML] Hepatitis B and C co-infections in some HIV-positive populations in Cameroon, West Central Africa: analysis of samples collected over more than a decade

JJN Noubiap, PV Aka, AJ Nanfack, LA Agyingi… - PloS one, 2015 - journals.plos.org
As people infected with the human immunodeficiency virus (HIV) in Sub-Saharan Africa live
longer due to availability of antiretroviral treatment (ART), so is the rise of associated …

[HTML][HTML] Alteration of the gut fecal microbiome in children living with HIV on antiretroviral therapy in Yaounde, Cameroon

WB Abange, C Martin, AJ Nanfack, LG Yatchou… - Scientific Reports, 2021 - nature.com
Multiple factors, such as immune disruption, prophylactic co-trimoxazole, and antiretroviral
therapy, may influence the structure and function of the gut microbiome of children infected …

[HTML][HTML] Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies

AC Ka'e, AJ Nanfack, G Ambada, MM Santoro… - Frontiers in …, 2023 - frontiersin.org
Antiretroviral therapy (ART) has improved the lifespan of people living with HIV. However,
their immune system remains in a state of sustained activation/inflammation, which favors viral …

Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon

…, CF Ntungen, SMN Tetang, AJ Nanfack… - The Pediatric …, 2011 - journals.lww.com
Background: Scale-up to antiretroviral therapy (ART) requires surveillance for HIV drug
resistance. With the goal of attaining 100% pediatric ART coverage in Cameroon, strategies to …

Characterization of drug resistance mutations in naïve and ART‐treated patients infected with HIV‐1 in Yaounde, Cameroon

…, J Fokam, D Takou, A Nanfack… - Journal of medical …, 2012 - Wiley Online Library
Currently the prevalence of HIV‐1 infection in Cameroon is 5.1%, CRF02_AG subtype is
responsible for about 50% of infections. Since an HIV‐1 drug resistance test is not yet available …

High burden of HBV-infection and atypical HBV strains among HIV-infected Cameroonians

…, L Ceccarelli, MM Santoro, A Nanfack… - Current HIV …, 2016 - ingentaconnect.com
Aim: To investigate the prevalence and genotypic profile of overt and occult hepatitis-B
infection (OBI) among HIV-infected individuals in Cameroon. Methods: 212 HIV-infected …

Characterization of HIV-1 Reservoirs in Children and Adolescents: A Systematic Review and Meta-Analysis Toward Pediatric HIV Cure

AC Ka'e, MM Santoro, A Nanfack, ENJ Semengue… - The Journal of …, 2024 - Elsevier
Objective To conduct a comprehensive, systematic review of the profile of HIV-1 reservoirs
in children and adolescents with perinatally acquired HIV infection. Study design …

[HTML][HTML] First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of …

…, F Cham, SM Sosso, ES Temgoua, AJ Nanfack… - … Resistance & Infection …, 2020 - Springer
Background Sub-Saharan African countries are transitioning to dolutegravir-based regimens,
even for patients with extensive previous drug exposure, including first-generation …